Skip to search formSkip to main contentSkip to account menu

KH902 fusion protein

Known as: conbercept 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Recombinant Fusion Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Comparison of the Efficacy of Three Loading Doses of Intravitreal Injection of Conbercept with Injection Combined with PDT for the Treatment of PCV
Purpose To compare the efficacy between initial 3-monthly intravitreal conbercept monotherapy and combination intravitreal… 
2020
2020
Reply to Comment on: Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study.
2020
2020
Observation on the efficacy of intravitreal conbercept injection for macular edema secondary to retinal vein occlusion
Objective To observe the efficacy of intravitreal injection of conbercept for macular edema secondary to retinal vein occlusion… 
2019
2019
Intravitreal Injection of Conbercept Combined with Ahemd Glaucoma Valve Implants and Panretinal Photocoagulation Treatment for Neovascular Glaucoma
Objective: To observe the clinical effects of intravitreal injection of conbercept combined with Ahemd glaucoma valve implant… 
2019
2019
Observation on the efficacy of single intravitreal injection of conbercept for the treatment of diabetic macular edema
Objective To observe the short-term efficacy of single intravitreal injection of conbercept in the treatment of diabetic macular… 
2018
2018
Observation of curative effect of intravitreal injection of conbercept in wet age‐related macular degeneration: Optical coherence tomography analysis after injection
To observe the clinical efficacy of intravitreal injection of conbercept in the treatment of wet age‐related macular degeneration… 
2018
2018
Optic coherence tomography angiography to evaluate preoperative intravitreal Conbercept before vitrectomy for proliferative diabetic retinopathy (PDR)
2017
2017
Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies.
AIM To appraise the effect of treatment for diabetic macular edema (DME) in proliferative stage with sufficient panrentinal… 
2015
2015
Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration
Objective To observe the clinical efficiency of intravitreal Conbercept on exudative age-related macular degeneration (eAMD… 
2015
2015
Effects of conbercept on human retinal microvascular endothelial cells barrier function and expression of VEGF in high glucose environment
Objective: To investigate the effects of conbercept on human retinal microvascular endothelial cells( hRMECs) barrier function… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)